In this section we explore the hurdles we face to live longer. These barriers to longevity are typically what stops us in our tracks, and generally viewed as common and natural causes of death. Not only do they shorten our lifespan but they also reduce our quality of life in our last years.
Even if a treatment today could provide you with the ability to live forever, it is highly likely that you would still be vulnerable to diseases such as Cancer, Alzheimer’s, and Parkinson’s. These existing barriers to longevity pose a significant risk to our pursuit of immortality.
As such, in this section we will take a closer look at the latest scientific and technological breakthroughs in the disease areas which pose the greatest risk of shortening our lifespan.
Highlighted research into barriers to longevity:
More research into barriers to longevity:
Yamanaka Factors Protect Against Neurodegeneration in Mice
A recent study has shown that partial reprogramming of brain cells using Yamanaka factors can protect against neurodegeneration in mice.
The Potential of a Personalized Anti-Cancer Vaccine
Research shows that an anti-cancer vaccine that is designed to target specific individual cancers can be engineered from probiotics.
Lipid Accumulation: A Key Driver for Parkinson’s Disease
Research suggests a connection between lipid accumulation and cellular senescence in dopaminergic neurons, leading to Parkinson's disease.
The Link Between Osteoporosis and Telomere Shortening
Osteoporosis is associated with telomere shortening, and research suggests a link between this chronic condition and accelerated aging.
The Role of Leukocyte Telomere Length in Alzheimer’s Disease
This recent study explores the relationship between leukocyte telomere length and the risk of developing Alzheimer's disease
Heparan Sulfate: A Potential Target in Alzheimer’s Disease
Recent research into the role of heparan sulfate may open new doors for treating neurodegenerative conditions such as Alzheimer's disease.
BFC1108 Blocks Cancer Cell Survival Mechanisms and Kills Them
Researchers have discovered a small molecule called BFC1108 that blocks cancer cell survival mechanisms and kills them
Gamma Oscillations Improve Cognition/Memory in Alzheimer Mice
Recent research has identified that enhanced gamma oscillations improve cognition/memory in Alzheimer's disease mouse models.
The VCAM1–ApoE Pathway may Slow Down Alzheimer’s Disease
The VCAM1–ApoE pathway improves microglial function, and may slow down the progression of Alzheimer’s and improve cognitive health.
Neuronal APOE4 Removal may Protect Against Alzheimer’s
Neuronal APOE4 removal enabled scientists to significantly reduce the progression of key Alzheimer’s related pathologies in a mouse model.
Microglial Activation Protects Against Tau Aggregates in Alzheimer’s
This study highlights the role of microglial activation in protecting against tau accumulation in the brain, a key feature of...
Better Education Improves Brain Health
Research suggest that better education improves brain health in older adults through robust structural integrity of brain networks.
PHDP5 in Alzheimer’s Disease: A Potential Therapeutic
A recent study highlights the potential of a peptide called PHDP5 in improving cognitive functions in Alzheimer's disease.
A Leap Forward in Alzheimer’s Research with Activated Protein C
Recent research into Activated Protein C (APC) offers new insights into its potential to alter the progression of Alzheimer's disease.
Potential of ABBV-CLS-484 in Cancer Immunotherapy & Anti-Aging
Recent research reveals potential of ABBV-CLS-484 (AC484) as a cancer immunotherapy and to reduce chronic inflammation linked to aging.
Exploring NXPH4: A Potential Biomarker for Cancer Progression
Recent studies have identified the protein NXPH4 as a potential biomarker for cancer, particularly colon cancer.
